imiquimod has been researched along with Hypermelanosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, T; Gu, Y; He, L; Huang, R; Lee, S; Liang, Y; Liu, Q; Liu, T; Lu, L; Wang, H; Yang, W; Zhang, F; Zhang, L; Zhang, P; Zhou, B; Zhou, J | 1 |
| Alexiades-Armenakas, M; Luebberding, S | 1 |
| Chimenti, S; Saraceno, R; Teoli, M | 1 |
1 review(s) available for imiquimod and Hypermelanosis
| Article | Year |
|---|---|
New tattoo approaches in dermatology.
Topics: Aminoquinolines; Animals; Bile Pigments; Cosmetic Techniques; Dermatology; Guinea Pigs; Humans; Hyperpigmentation; Imiquimod; Laser Therapy; Lasers, Solid-State; Low-Level Light Therapy; Skin; Stereotyping; Tattooing; Treatment Outcome | 2014 |
2 other study(ies) available for imiquimod and Hypermelanosis
| Article | Year |
|---|---|
A Murine Point Mutation of Sgpl1 Skin Is Enriched With Vγ6 IL17-Producing Cell and Revealed With Hyperpigmentation After Imiquimod Treatment.
Topics: Animals; Homeostasis; Hyperpigmentation; Imiquimod; Mice; Mice, Knockout; Point Mutation | 2022 |
Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Hydroxyurea; Hyperpigmentation; Imiquimod; Male; Myeloproliferative Disorders; Nail Diseases; Skin Neoplasms | 2008 |